0001628280-24-001196.txt : 20240111 0001628280-24-001196.hdr.sgml : 20240111 20240111171230 ACCESSION NUMBER: 0001628280-24-001196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nouri Alaleh CENTRAL INDEX KEY: 0001599418 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 24529945 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-232-7200 MAIL ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 wk-form4_1705011139.xml FORM 4 X0508 4 2024-01-09 0 0001588978 PROCEPT BioRobotics Corp PRCT 0001599418 Nouri Alaleh C/O PROCEPT BIOROBOTICS CORPORATION 150 BAYTECH DRIVE SAN JOSE CA 95134 0 1 0 0 EVP, CLO, CORP. SEC. 1 Common Stock 2024-01-09 4 M 0 16000 4.56 A 63351 D Common Stock 2024-01-09 4 S 0 16000 44.9672 D 47351 D Stock Option (Right to Buy) 4.56 2024-01-09 4 M 0 16000 0 D 2029-12-12 Common Stock 16000 13697 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. Includes 418 shares acquired on May 12, 2023 under the Issuer's 2021 Employee Stock Purchase Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.95 to $45.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The Stock option was granted on December 12, 2019 and vested over a four year period. /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri 2024-01-11